Abstract
Breast cancer is one of the most common cancers and is a leading cause of mortality in women. The TG.NK transgenic mouse line expresses the c-neu breast cancer oncogene under the control of an MMTV promoter and appears to be a useful animal model for evaluation of intervention strategies to delay/prevent breast cancer. Fiber-rich nonpurified diet (NTP-2000), as compared to a purified diet (AIN-76A), has previously been shown to significantly delay the development of mammary cancer in the TG.NK model. Four-week old hemizygous TG.NK female mice with MMTV/c-neu oncogene were fed NTP-2000 diet containing the retinoid analogue 4-hydroxyphenyl retinamide (4-HPR) at 5 mM/kg or an arotinoid Ro 40-8757 at 2 and 3 mmol/kg for 26 weeks. The 4-HPR at 5 mmol/kg diet delayed the development of palpable tumors up to 24 weeks, but by 26 weeks, the incidence was not significantly different from the NTP-2000 diet control group. However, the 4-HPR diet markedly decreased the average weight of the tumors at 26 weeks. The 4-HPR diet also caused a significant increase in body weight without an increase in food consumption. Arotinoid Ro-40-8757 at both doses inhibited the development of mammary tumors for the duration of the study. However, the Ro 40-8757 at 3 mmol/kg appeared to be toxic as indicated by a significant depression of the average body weight with alopecia and skin scaling in some mice. Our observations with TG.NK transgenic mouse and fiber-rich diet (NTP-2000) indicate that the arotinoid Ro 40-8757 has a markedly higher inhibitory effect on the development of mammary cancer than 4-HPR. Studies to evaluate genetic changes and expression of hormonal receptors and growth factors associated with the inhibition of mammary cancer development by the retinoid analogues are in progress.
Similar content being viewed by others
References
Miller BA, Ries LAG, Hankey BF, Kosary CL, Harras A, Devesa SS, Edwards BK (eds): SEER Cancer Statistics Review: 1973–1990. National Cancer Institute. NIH Pub No 93-2789, 1993
Clarke R: Animal models of breast cancer: Their diversity and role in biomedical research. Breast Cancer Res Treat 39: 1–6, 1996
Amundadottir TL, Merlino G, Dickson RB: Transgenic mouse models for breast cancer. Breast Cancer Res Treat 39: 119–135, 1996
Muller WJ, Sinn E, Pattengale PK, Wallace R, Leder P: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54: 105–115, 1988
Tennant RW, Rao GN, Russfield A, Seilkop S, Braun AG: Chemical effects in transgenic mice bearing oncogenes expressed in mammary tissue. Carcinogenesis 14: 29–35, 1993
Rao GN, Ney E, Herbert RA: Influence of diet on mammary cancer in transgenic mice bearing oncogene expressed in mammary tissue. Breast Cancer Res Treat 45: 149–158, 1997
Rose DP: Dietary fiber and breast cancer. Nutr Cancer 13: 1–8, 1990
Rose DP, Goldman M, Connolly JM, Strong LE: High-fiber diet reduces serum estrogen concentrations in premenopausal women. Am J Clin Nutr 54: 520–525, 1991
Moon RC, Mehta RG, Detrisac CJ: Retinoids as chemopreventive agents for breast cancer. Cancer Detect Prev 16: 73–79, 1992
Moon RC, Mehta RG, Rao KVN: Retinoids and cancer in experimental animals. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids. Raven Press, New York, 1994, 2nd ed, pp 573–595
Hartmann D, Eliason J, Teelmann K, Kaufmann F, Klaus M: Ro 40-8757: A novel arotinoid with anticancer activity. In: Livera MA, Packer L (eds) Retinoids: Progress in Research and Clinical Application. Marcel Dekker, New York, 1993, pp 491–505
Taketo M, Schroeder AC, Mobraaten LE, Gunning KB, Hanten G, Fox RR, Rodrick TH, Stewart CL, Lilly F, Hansen CT: FVB/N: an inbred mouse strain preferable for transgenic analyses. Proc Natl Acad Sci USA 88: 2065–2069, 1991
Webster MA, Muller WJ: Mammary tumorigenesis and metastasis in transgenic mice. Sem Cancer Biol 5: 69–76, 1994
National Research Council: Guide for the Care and Use of Laboratory Animals. US Govt. Printing Office, Washington DC, NIH Pub No 85-23, 1985
Rao GN: New nonpurified diet (NTP-2000) for rodents in the National Toxicology Program's toxicology and carcinogenesis studies. J Nutr 127: 842s–846s, 1997
Rao GN: New diet (NTP-2000) for rats in the National Toxicology Program toxicology and carcinogenesis studies. Fund Appl Toxicol 32: 102–108, 1996
Steel RGD, Torrie JH: Principles and Procedures of Statistics: A Biometrical Approach. 2nd ed. McGraw-Hill, New York, 1980, pp 95–100
Cox DR, Oakes D: Analysis of Survival Data. Chapman and Hall, New York, 1984, pp 104–107
Hollander M, Wolfe WA: Nonparametric Statistical Methods. John Wiley, New York, 1973, pp 68–71
Koch GG, Atkinson SS, Stokes ME: Poisson regression. In: Kotz S, Johnson NL, Read CB (eds). Encyclopedia of Statistical Sciences. John Wiley, New York, 1986, Vol 7, pp 32–41
Lindamood C III, Giles HD, Hill DL: Preliminary toxicity profile of arotinoids SMR-2 and SMR-6 in male B6D2F1 mice. Fund Appl Toxicol 8: 517–530, 1987
Gudas LJ, Sporn MB, Roberts AB: Cellular biology and biochemistry of the retinoids. In: Sporn MB, Roberts AB, Goodman DS (eds) The Retinoids. Raven Press, New York, 1994, 2nd ed, pp 443–520
Lotan R: Role of retinoids and their nuclear receptors in the development and prevention of upper aerodigestive tract cancers. Environ Health Perspect 105: 985–988, 1997
Lohnes D, Kasner P, Dierich A, Mark M, LeMeur M, Chambon P: Function of retinoic acid receptors in the mouse. Cell 73: 643–658, 1993
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rao, G.N., Ney, E. & Herbert, R.A. Effect of retinoid analogues on mammary cancer in transgenic mice with c-neu breast cancer oncogene. Breast Cancer Res Treat 48, 265–271 (1998). https://doi.org/10.1023/A:1005957620881
Issue Date:
DOI: https://doi.org/10.1023/A:1005957620881